T. Rowe Price Associates’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-22,550
| Closed | -$49K | – | 3065 |
|
2024
Q3 | $49K | Hold |
22,550
| – | – | ﹤0.01% | 2929 |
|
2024
Q2 | $117K | Hold |
22,550
| – | – | ﹤0.01% | 2726 |
|
2024
Q1 | $121K | Hold |
22,550
| – | – | ﹤0.01% | 2746 |
|
2023
Q4 | $176K | Hold |
22,550
| – | – | ﹤0.01% | 2584 |
|
2023
Q3 | $90K | Hold |
22,550
| – | – | ﹤0.01% | 2684 |
|
2023
Q2 | $72K | Hold |
22,550
| – | – | ﹤0.01% | 2749 |
|
2023
Q1 | $61K | Buy |
22,550
+10,400
| +86% | +$28.1K | ﹤0.01% | 2764 |
|
2022
Q4 | $44K | Buy |
+12,150
| New | +$44K | ﹤0.01% | 2827 |
|
2022
Q3 | – | Sell |
-8,092
| Closed | -$78K | – | 3045 |
|
2022
Q2 | $78K | Buy |
8,092
+4
| +0% | +$39 | ﹤0.01% | 2801 |
|
2022
Q1 | $96K | Sell |
8,088
-2,040
| -20% | -$24.2K | ﹤0.01% | 2845 |
|
2021
Q4 | $330K | Buy |
10,128
+5,220
| +106% | +$170K | ﹤0.01% | 2558 |
|
2021
Q3 | $219K | Buy |
+4,908
| New | +$219K | ﹤0.01% | 2686 |
|
2021
Q1 | – | Sell |
-4,759
| Closed | -$516K | – | 2872 |
|
2020
Q4 | $516K | Buy |
4,759
+629
| +15% | +$68.2K | ﹤0.01% | 2222 |
|
2020
Q3 | $365K | Buy |
4,130
+1,880
| +84% | +$166K | ﹤0.01% | 2214 |
|
2020
Q2 | $240K | Sell |
2,250
-6,455
| -74% | -$689K | ﹤0.01% | 2316 |
|
2020
Q1 | $516K | Buy |
8,705
+4,455
| +105% | +$264K | ﹤0.01% | 1977 |
|
2019
Q4 | $294K | Sell |
4,250
-3,466
| -45% | -$240K | ﹤0.01% | 2316 |
|
2019
Q3 | $801K | Sell |
7,716
-6,527
| -46% | -$678K | ﹤0.01% | 1903 |
|
2019
Q2 | $1.32M | Sell |
14,243
-1,485
| -9% | -$138K | ﹤0.01% | 1726 |
|
2019
Q1 | $1.44M | Sell |
15,728
-15,263
| -49% | -$1.39M | ﹤0.01% | 1700 |
|
2018
Q4 | $1.73M | Sell |
30,991
-1,730
| -5% | -$96.4K | ﹤0.01% | 1601 |
|
2018
Q3 | $3.9M | Sell |
32,721
-27
| -0.1% | -$3.22K | ﹤0.01% | 1484 |
|
2018
Q2 | $3.34M | Buy |
32,748
+20
| +0.1% | +$2.04K | ﹤0.01% | 1487 |
|
2018
Q1 | $4.25M | Buy |
32,728
+1,732
| +6% | +$225K | ﹤0.01% | 1449 |
|
2017
Q4 | $3.02M | Buy |
30,996
+130
| +0.4% | +$12.6K | ﹤0.01% | 1479 |
|
2017
Q3 | $4.54M | Buy |
+30,866
| New | +$4.54M | ﹤0.01% | 1435 |
|